Latest News & Updates
Breaking News
12 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
Sun Pharma Achieves Rs. 33,500 Crore Cumulative R&D Investment Targeting Global Specialty Pipeline
Sun Pharma's Rs. 33,500 crore cumulative R&D spend raises near-term demands on process validation, tech transfer, and global regulatory submissions.
Pharma Now Editorial Team
NATCO Pharma Acquires 49% Stake in Adcock Ingram in Rs. 1,069 Crore Deal
NATCO Pharma raises its Adcock Ingram stake to 49% in a Rs. 1,069 crore deal, triggering dual SAHPRA-CDSCO compliance requirements.
Pharma Now Editorial Team
Gennova Biopharma Sells mRNA Business to Immunoscript in Rs. 139.5 Crore Divestiture
Gennova Biopharma divests its mRNA platform to Immunoscript for Rs. 139.5 crore, reflecting post-COVID commercial pressures on mRNA manufacturing.
Pharma Now Editorial Team
FDA Finalizes Pre-Submission Facility Correspondence Guidance for Priority ANDA Review Timelines
FDA finalizes PFC guidance for priority ANDAs under GDUFA III, giving regulatory teams a concrete framework for optimizing review timelines.
Pharma Now Editorial Team
